Top Story

Elevated blood glucose linked to early death, other events in patients with acute HF

January 8, 2015

Slight elevation in blood glucose was associated with early mortality, future diabetes and future hospitalization among patients with acute HF, even those without diabetes, in a recent study.

“Although diabetes is a known risk factor for developing [HF], this is the first time that it has been shown that [HF] predisposes people to developing diabetes,” researcher Douglas S. Lee, MD, PhD, FRCPC, said in a press release.

New trial to focus on patients with multiple chronic diseases

January 7, 2015
A new NIH-funded, multicenter, clinical trial will be the first to focus on the management of patients with chronic kidney disease, diabetes, and hypertension in…
Frank M. Sacks In the Journals

Glycemic index did not affect CV risk factors, insulin resistance

December 16, 2014
Diets containing foods with low glycemic index of dietary carbohydrate did not help patients with obesity or overweight achieve better insulin sensitivity, lipid levels…
Kamlesh Khunti In the Journals

Hypoglycemia increased risks for CV events, death in patients with diabetes on insulin

December 15, 2014
Insulin-treated patients with diabetes who experience hypoglycemia are also more likely to experience cardiovascular events and die from any cause, according to research…
CME
Risk Management in the Cardiovascular Disease Arena

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »

Filter By:

In the Journals

CTA provided accurate assessment of arterial plaque in patients with diabetes

April 22, 2014
Quantitative plaque analysis with coronary CTA was an accurate assessment of calcified and noncalcified arterial plaque in patients with diabetes…
In the Journals

CTA provided accurate assessment of arterial plaque in patients with diabetes

Cardiology Today, June 2014
Quantitative plaque analysis with coronary CTA was an accurate assessment of calcified and noncalcified arterial plaque in patients with diabetes…
Meeting News Coverage

Philip Schauer, MD, offers investigator insight into 3-year STAMPEDE results

April 6, 2014
WASHINGTON — In this video, Philip Schauer, MD, director of the Cleveland Clinic Bariatric and Metabolic Institute, outlines the 3-year…
In the Journals

Lifestyle changes reduced mortality, diabetes rate in adults with IGT

April 3, 2014
The potential for weight loss and exercise to prevent deaths from cardiovascular disease and all-causes in adults with impaired glucose tolerance is…
Meeting News CoverageVideo

Darren K. McGuire, MD, MHSc, on the 3-year STAMPEDE trial results

April 1, 2014
WASHINGTON — In this video, Darren K. McGuire, MD, MHSc, professor of internal medicine and Dallas Heart Ball Chair for research on heart…
In the Journals

Intensive BP, lipid regimens improved CVD outcomes in diabetes

March 31, 2014
Compared with combined standard treatment options, intensive blood pressure or intensive glycemia treatment alone were shown to improve major…
Meeting News CoveragePerspective

Bariatric surgery provided long-term diabetes control out to 3 years

March 31, 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News CoveragePerspectivePublication Exclusive

Bariatric surgery provided long-term diabetes control out to 3 years

Cardiology Today, May 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

March 30, 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

Cardiology Today, May 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
More Headlines »